Outbreak of lassa fever in Nigeria: measures for prevention and control by Mofolorunsho, Kehinde Charles




Outbreak of lassa fever in Nigeria: measures for prevention and control 
 
Kehinde Charles Mofolorunsho1,& 
 
1Department of Microbiology, Faculty of Natural Sciences, Kogi State University Anyigba, Nigeria 
 
&Corresponding author: Kehinde Charles Mofolorunsho, Department of Microbiology, Faculty of Natural Sciences, Kogi State University Anyigba, 
Nigeria 
 
Key words: Lassa virus, haemorrhagic fever, mastomys natalensis, Nigeria 
 
Received: 22/01/2016 - Accepted: 10/04/2016 - Published: 20/04/2016 
 
 
Pan African Medical Journal. 2016; 23:210 doi:10.11604/pamj.2016.23.210.8923 
This article is available online at: http://www.panafrican-med-journal.com/content/article/23/210/full/ 
 
© Kehinde Charles Mofolorunsho et al. The Pan African Medical Journal - ISSN 1937-8688. This is an Open Access article distributed under the terms of the Creative 
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided 























Pan African Medical Journal – ISSN: 1937- 8688   (www.panafrican-med-journal.com) 
Published in partnership with the African Field Epidemiology Network (AFENET). (www.afenet.net) 
 






Page number not for citation purposes 2 
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Lassa fever, an acute viral haemorrhagic fever, extremely virulent 
and often infectious, occurs very frequently in different parts of 
Nigeria [1-4] and affects approximately 100,000-500,000 persons 
per year in West Africa [5,6]. The illness was discovered in Lassa, 
Borno State where it was first reported. It is caused by the Lassa 
fever virus, a single stranded RNA virus belonging to 
the arenaviridae family [7, 8]. 
  
The incubation period for Lassa fever varies from 6 – 21 days. It is 
symptomatic and usually characterized by fever, myalgia, nausea, 
vomiting, sore throat, abdominal and chest pains. Illness may 
progress to more serious symptoms including haemorrhaging, 
neurological problems, hearing loss, tremors and encephalitis [8-
10]. 
  
Lassa virus is zoonotic and infected rodents in 
the mastomysnatalensis species complex are reservoirs capable of 
excreting the virus through urine, saliva, excreta and other body 
fluids to man [7,11]. Secondary human – to- human spread within a 
community may occur through inhalation or ingestion. Nosocomial 
transmission is also not uncommon [10, 12]. 
  
Lassa fever is endemic in parts of West Africa including Sierra 
Leone, Liberia and Nigeria [10]. Outbreaks of the disease have been 
reported in various parts of Nigeria and the most recent of them is 
the on-going 2016 outbreak. There have been several Lassa fever 
outbreaks since it was first reported in 1969 with the worst outbreak 
recorded in 2012 where 623 cases including 70 deaths were 
reported from 19 out of the 36 states [8, 9, 13, 14]. In the current 
outbreak, cases are so far being reported in Seventeen states with 
212 suspected cases and 63 deaths. Case fatality rate has been put 
at 37.9% [15]. 
  
Since Lassa fever presents with no specific symptoms, clinical 
diagnosis is often difficult especially at the early onset of disease. 
Accurate diagnosis therefore can be assisted with differential 
laboratory testing, clinical manifestations, epidemiological findings 
since definitive diagnosis requires investigations available only in 
highly specialized laboratories [13, 16]. 
  
Early treatment of Lassa fever is very important for survival and 
requires specialized treatment using the guanosine analogue 
ribavirin. Care must also be taken to avoid spread of the disease in 
hospital settings [14,17]. 
  
Due to the absence of vaccine against the virus and the impractical 
control of the rodent host (mastomys species) population, control 
measures are limited to keeping rodents out of homes and food 
supplies and also maintaining proper personal hygiene. Using these 
rodents as food source should be discouraged [5, 18]. 
Enlightenment and awareness of the public on risk factors 
associated with spread of disease is important for prevention. 
Protective measures should be put in place to reduce human 
infection. Infected persons should be isolated and their body fluids 
and excrements properly disposed. Healthcare workers should take 
proper precautions in order to curtail nosocomial spread of disease 




In conclusion, the current outbreak of Lassa fever in Nigeria can be 
controlled effectively by adopting proper standard precautions in 
hospitals as well as communities. Educating the public on the mode 
of transmission of this virus and the need for proper hygiene and 
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